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Versican V2 assembles the extracellular matrix surrounding the
nodes of ranvier in the CNS
Abstract
The CNS-restricted versican splice-variant V2 is a large chondroitin sulfate proteoglycan incorporated
in the extracellular matrix surrounding myelinated fibers and particularly accumulating at nodes of
Ranvier. In vitro, it is a potent inhibitor of axonal growth and therefore considered to participate in the
reduction of structural plasticity connected to myelination. To study the role of versican V2 during
postnatal development, we designed a novel isoform-specific gene inactivation approach circumventing
early embryonic lethality of the complete knock-out and preventing compensation by the remaining
versican splice variants. These mice are viable and fertile; however, they display major molecular
alterations at the nodes of Ranvier. While the clustering of nodal sodium channels and paranodal
structures appear in versican V2-deficient mice unaffected, the formation of the extracellular matrix
surrounding the nodes is largely impaired. The conjoint loss of tenascin-R and phosphacan from the
perinodal matrix provide strong evidence that versican V2, possibly controlled by a nodal receptor,
organizes the extracellular matrix assembly in vivo.
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The CNS-restricted versican splice-variant V2 is a large chondroitin sulfate proteoglycan incorporated in the extracellular matrix sur-
rounding myelinated fibers and particularly accumulating at nodes of Ranvier. In vitro, it is a potent inhibitor of axonal growth and
therefore considered to participate in the reduction of structural plasticity connected to myelination. To study the role of versican V2
duringpostnatal development,wedesigned anovel isoform-specific gene inactivation approach circumventing early embryonic lethality
of the complete knock-out and preventing compensation by the remaining versican splice variants. These mice are viable and fertile;
however, they displaymajormolecular alterations at the nodes of Ranvier.While the clustering of nodal sodium channels and paranodal
structures appear in versican V2-deficient mice unaffected, the formation of the extracellular matrix surrounding the nodes is largely
impaired. The conjoint loss of tenascin-R and phosphacan from the perinodal matrix provide strong evidence that versican V2, possibly
controlled by a nodal receptor, organizes the extracellular matrix assembly in vivo.
Introduction
Neuronal and glial cells of the adult CNS are surrounded by
specialized extracellular matrices (ECMs) that assemble during
maturation and replace the loosemeshwork of the late embryonic
and early postnatal phase [for review, see Bandtlow and Zimmer-
mann (2000), Yamaguchi (2000), Rauch (2004), and Zimmer-
mann and Dours-Zimmermann (2008)]. Both juvenile and ma-
ture forms of the CNS matrix are composed of chondroitin
sulfate proteoglycans (CSPGs), tenascins, link proteins, and hya-
luronan. Themajority of theCSPGs belongs to the lectican family
that includes brevican, neurocan, aggrecan, and versican. Lecti-
cans share N- and C-terminal globular structures (G1 and G3,
respectively) separated by unique glycosaminoglycan (GAG) car-
rying middle portions of variable size. Moreover, alternative in-
corporation of the two glycosaminoglycan attachment regions,
GAG- and GAG-, results in four versican splice variants (V0
contains the GAG- and GAG- domain, V1 only GAG-, V2
only GAG-, and V3 neither of these domains) (Dours-
Zimmermann and Zimmermann, 1994; Zako et al., 1995).
All lecticans bind via their G1 domain to hyaluronan. This
interaction is stabilized by one of four link proteins (HAPLN1–4)
(Spicer et al., 2003). In addition, the lectin-like element in the
C-terminal G3 domain displays in vitromoderate-to-high bind-
ing affinities toward tenascin-R (TnR) (Aspberg et al., 1997),
tenascin-C (TnC) (Day et al., 2004), and sulfated glycolipids
(Miura et al., 1999). The trimeric TnR and the hexameric TnC
glycoproteins may cross-link the G3 domains of lecticans and,
thus, tie up the extracellular network (Lundell et al., 2004). Fi-
nally, phosphacan, a secreted CSPG form of the receptor-like
protein tyrosine phosphatase  (RPTP) (Maurel et al., 1994),
joins the complex.
In the adult CNS, versicanV2 andHAPLN2/Bral1 are the prom-
inent components of the white matter ECM and particularly accu-
mulate at the nodes of Ranvier (Schmalfeldt et al., 1998, 2000;
Oohashi et al., 2002; Melendez-Vasquez et al., 2005). Conversely,
aggrecan, HAPLN4/Bral2, and neurocan associate with perineuro-
nalnets(Bru¨ckneretal.,2000;Bekkuetal.,2003).Brevican,hyaluronan,
TnR, and phosphacan are observed in both of these meshworks.
Since lecticans strongly inhibit axonal growth in vitro, these
specialized ECMs might participate in consolidating myelinated
fiber tracts, limiting structural plasticity, and restricting regener-
ation in thematuratingCNS (Yamaguchi, 2000; Zurn andBandt-
low, 2006; Galtrey and Fawcett, 2007; Zimmermann and Dours-
Zimmermann, 2008). Furthermore, they may regulate the
assembly of axoglial complexes and facilitate the induction and
propagation of action potentials at the axon initial segments
(AISs) and the nodes of Ranvier (Bru¨ckner et al., 1993, 2006;
Poliak and Peles, 2003; Salzer, 2003; Sherman and Brophy, 2005;
Hedstrom and Rasband, 2006), or they could fulfill neuroprotec-
tive functions (Morawski et al., 2004).
To further explore these potential roles in vivo, we have now
suppressed the expression of versican V2, one of the main con-
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stituents of the mature neural ECM. We
avoided the early embryonic lethality of
the complete gene knock-out (Mjaatvedt
et al., 1998) by using an unconventional
isoform-specific gene targeting strategy.
The newly generatedmouse strain is viable
and fertile, but displays major aberrations
in the matrix assembly.
Materials andMethods
Generation of versican V0/V2 KO mice. Using a
targeting vector containing a floxed neomycin-
thymidine kinase (neo-tk) selection cassette
under the control of the HSV-tk promoter, we
introduced an ER-retention signal followed by
an early translational stop codon into the
GAG- encoding exon VII of the mouse versi-
can gene (codon-insertion KDEL-stop after
E749, Swiss-ProtQ62059) (Fig. 1). The two 3.9-
kb-long genomic arms of the construct in-
cluded corresponding parts of exonVII plus ad-
jacent intron sequences, previously cloned
from syngeneic DNA by PCR (primer se-
quences and PCR conditions available on re-
quest). Electroporation of the linearized con-
struct into R1 129Sv embryonic stem (ES) cells
(Nagy et al., 1993), selection, and screening of
ES cell clones were done as previously described
(Talts et al., 1999). Homologous recombinants
were identified by Southern blot analysis using
a digoxigenin (DIG)-labeled probe (Roche Ap-
plied Science) downstream of the target site.
The ES cells were injected into C57BL/6J blas-
tocysts and transferred into a foster mother.
The chimeric offspring were cross-bred with
C57BL/6J WT mice. Germline transmission of
the mutated versican allele was verified by
Southern blotting and long-distance PCR.
The floxed neo-tk selection cassette was re-
moved in vivo by cross-breeding heterozygous
V0/V2 neo-tk animals with a mouse strain expressing the CRE transgene
under the control of the cytomegalovirus promoter (Schwenk et al.,
1995). Correct target integration and recombinationwas verified by PCR
and sequencing of the modified allele. The mutant mice, named
VCAN(tm1Zim), were backcrossed to establish 129Sv inbred and
C57BL/6J outbred strains.
Northern blotting and quantitative RT-PCR. Primary fibroblasts were
isolated from E14.5 embryos and maintained in culture (Talts et al.,
1999). Total RNA extraction, Northern blotting, and DIG labeling of a
riboprobe hybridizing with the hyaluronan-binding region of the mouse
versican mRNA (HABR, positions 458–1203, GenBank D28599) were
done as described previously (Zimmermann et al., 1994).
To determine relative amounts of versican mRNA expression in the
mutant versus WT mouse brains, quantitative RT-PCR was performed
with an ABI PRISM 7700 Sequence Detection System using the Quanti-
Tect SYBR Green RT-PCR Kit (Qiagen). Total RNAs from brains of
littermates were extracted with RNeasy Protect kit (Qiagen). Primers
detecting the different splice variants of versican were designed to cover
the isoform-specific exon–exon boundaries (supplemental Table 1,
available at www.jneurosci.org as supplemental material). Threshold cy-
cle (CT) values from at least three animals per genotype and per devel-
opmental time point were normalized against glyceraldehyde-3-
phosphate dehydrogenase mRNA (mGAPDH, GenBank M32599) as
endogenous control. RelativemRNA amounts (2CT) were calculated
on the basis of the comparative CT method, applying the formula
CT  (CT KO  CT WT). The CT of each measurement was
determined by subtracting the GAPDH CT from the versican CT value
(CT VC CT GAPDH CT).
Antibodies. All polyclonal antibodies have been raised against recom-
binant core protein fragments as described previously (Zimmermann et
al., 1994). The GAG--specific antibodies (Schmalfeldt et al., 2000) rec-
ognize the N-terminal portion of this domain of mouse versican (amino
acids 362–585, Swiss-Prot Q62059), also present in the potentially trans-
lated truncated V0/V2 polypeptide of the mutant mice. The GAG- an-
tigen comprised amino acids 2750–3040. Both versican fragments were
used to generate rabbit and guinea pig antisera in parallel. Recombinant
portions of aggrecan (mAC-IGD: residues 368–481 and mAC-GAG:
1678–1896; Swiss-Prot Q61282) and neurocan (mNC-C: residues 645–
944; Swiss-Prot P55066) served as antigens for the immunization of
guinea pigs. Rabbit antisera against rat brevican (Thon et al., 2000) and
TnR (Day et al., 2004) were kind gifts of Takako Sasaki (University of
Erlangen, Erlangen, Germany) and Anders Aspberg (University of Lund,
Lund, Sweden), respectively.
The anti-phosphacan monoclonal antibody 3F8 (Rauch et al., 1991)
was purchased from the Developmental Studies Hybridoma Bank (Uni-
versity of Iowa). Other commercial antibodies used were as follows: goat
anti-human contactin-1 polyclonal antibodies (R&D Systems), mouse
monoclonal antibody K14/16 against the Kv1.2 -subunit (Millipore),
rabbit anti-rat-voltage gated sodium channel 1.6 (Nav1.6) polyclonal
antibodies (Alomone Labs), mouse monoclonal antibody anti-Caspr
clone K65/35 (obtained from the UC Davis/NIH NeuroMab Facility,
University of California), rabbit anti-humanmyelin basic protein (MBP)
polyclonal antibodies (Dako), mouse anti-humanMBPmonoclonal an-
tibody 67–74 (Millipore Bioscience Research Reagents), rabbit poly-
clonal antibodies against bovine glial fibrillary acidic protein (GFAP)
(Dako), mouse (pan-)sodium channel monoclonal antibody K58/35
Figure 1. Generation of versican V0/V2 KO mice. A, Intron/exon organization of the mouse versican gene giving rise to four
different versican isoforms (V0–V3) due to alternative splicing of exons VII and VIII encoding the GAG-attachment domains
(GAG- and GAG-). Gray box shows region of interest displayed in B. B, Locus diagram and targeting strategy: introduction of
an ER retention signal, a translational stop codon, and a floxed neo-tk cassette into exon VII of the versican gene (V0/V2 neo-tk).
Removal of selection cassette by cross-breedingwith a CRE-deleter strain leaves only the KDEL coding sequence and a stop codon
plus one loxP site in exon VII of themutated versican allele (V0/V2). Corresponding restriction fragments detected in Southern
blotaredepictedbelow.C,SouthernblotanalysisofgenomicDNAfrommiceandEScells: theDIGprobedownstreamofthetargeting locus
hybridizes to the 17 kb EcoRI fragment of the WT allele, which converts to a 6.6 kb fragment in versican V0/V2-null mutants. BamHI
restriction allows a distinction betweenWT, V0/V2neo-tk, andV0/V2 alleles, confirming the successful targeting.
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(Sigma), and mouse anti-neurofilament-200 monoclonal antibody
NE14 (Sigma).
Protein extraction and immunoblots. Brain extracts were prepared as
described previously (Schmalfeldt et al., 1998); each step of sample prep-
arations included Pefabloc and “complete protease inhibitors” (Roche
Applied Science). In brief, tissues were disrupted in a Polytron homoge-
nizerwith 4 volumes of extraction buffer (0.5MNaCl, 50mMTris, pH7.5,
25 mM EDTA, 0.5% Nonidet P-40) and stirred overnight at 4°C. The
homogenates were centrifuged at 100,000  g for 1 h and the superna-
tants dialyzed against chondroitinase buffer (40 mM Tris, 40 mM sodium
acetate, 10mM EDTA, pH 8). The protein concentration was determined
with the BCA System (Pierce).
Samples were run on 4–15%PHAST polyacrylamide gels (GEHealth-
care) under reducing conditions and blotted onto Immobilon-P mem-
branes (Millipore) by diffusion transfer at 70°C for 20 min. Alkaline
phosphatase-conjugated secondary antibodies (Biosource or Jackson
ImmunoResearch Laboratories) and color reaction with Western Blue
substrate (Promega) were used. To detect lecticans, samples were di-
gested with chondroitinase ABC (Seikagaku) (1–2 mU/g protein) at
37°C overnight before electrophoresis. Spentmedium from primary em-
bryonic fibroblast culture was extensively dialyzed against chondroiti-
nase buffer before chondroitinase ABC digestion.
Immunohistochemistry and immunofluorescence. All animal studies
were approved by our institutional review boards. Animals were killed by
CO2 inhalation and decapitated. The tissues were dissected, immediately
fixed in 4% paraformaldehyde (PFA) in PBS, paraffin embedded, and
sectioned according to routine protocols. If needed, unmasking of the
antigen before staining was done in a controlled antigen-retrieval device
(FSG 120-T/T from Milestone), filled with appropriate buffer (10 mM
trisodium citrate, pH 6.0, or 2 mM Tris, 1.7 mM EDTA, 1 mM trisodium
citrate, pH 7.8).
In some cases, mice were anesthetized with a lethal dose of pentobar-
bital and transcardially perfused with PBS, followed by perfusion–fix-
ation with 4% PFA in PBS as described previ-
ously (Beggah et al., 2005). Brains and spinal
cords were removed, postfixed overnight at
4°C, and either paraffin embedded or cryopro-
tected and rapidly frozen in O.C.T. compound
(Tissue-Tek).
Immunohistochemistry followed the avidin-
biotinylated peroxidase method (VEC-
TASTAINElite ABCReagent, Vector Laborato-
ries) using biotinylated secondary antibodies
from Jackson ImmunoResearch Laboratories
[biotin-SP-conjugated donkey anti-goat,
guinea pig, or rabbit IgG (HL)]. Counter-
staining was done with Mayer’s hematoxylin.
With mouse monoclonal primary antibodies,
the M.O.M. kit (Vector Laboratories) was used
to avoid nonspecific reactions.
To stain hyaluronan in tissue sections, bio-
tinylated hyaluronic acid-binding protein (B-
HABP) (Seikagaku) was applied as 0.5 g/ml
solution in PBS overnight at 4°C, then detected
with the ABC method.
Hyaluronan was eliminated from the tissue
sections by pretreatmentwith hyaluronate lyase
from Streptomyces hyalurolyticus (Sigma) in 30
mM sodium acetate, 125mMNaCl, pH 5.2, con-
taining “complete protease inhibitors.” Diges-
tions went on for 2 h at 37°C in a humid cham-
ber. Control sections were processed in parallel
with buffer alone. Sections were washed with
PBS before blocking and immunostaining.
Immunofluorescence staining by standard
procedures used Alexa secondary antibodies:
Fluor-488 or Fluor-594 highly cross-adsorbed
goat anti-rabbit, -guinea pig, or -mouse IgG
(HL), or Fluor-594 donkey anti-goat. For tri-
ple immunofluorescence, Alexa Fluor-488 don-
key anti-rabbit, Alexa Fluor-555 donkey anti-goat, and Alexa Fluor-647
donkey anti-mouse IgGs were used. Counterstaining was with Hoechst
H33258 bis-benzimide (all from Invitrogen). Blocking reagent of the
M.O.M. kit was used for mouse primary antibodies.
Photomicrographs were taken with an Olympus BX61 microscope
equipped with an F-view camera. The image capture was controlled with
the AnalySISPro software (Soft Imaging System). Confocal laser scan-
ningmicroscopywas donewith a Leica TCS4D, and 3D image processing
using IMARIS software (Bitplane).
Electrophysiology. Analysis of compound action potentials (CAPs) of
mouse optic nerves were essentially done as described previously (Allen
et al., 2006). Measurements were performed on optic nerves from seven
wild-type and four V0/V2-knock-out mice. All animals were adults and
deduced from the 10th generation of the same C57BL/6J backcrossing.
Optic nerves were carefully dissected, cut behind the orbit and in close
vicinity to the optic chiasma. They were gently freed from surrounding
connective tissue, placed in a circulation system, and superfused with
artificial CSF (aCSF) containing 126mMNaCl, 3 mMKCl, 2.5 mMCaCl2,
4 mM MgCl2, 1.25 mM NaH2PO4, 26 mM NaHCO3, and 10 mM glucose
(Stys et al., 1991). The aCSF was continually oxygenated with a mix of
95% O2 and 5% CO2. The nerves were allowed to equilibrate for 1 h
before starting the experiment. Suction electrodes (A-M Systems) back-
filled with aCSF were used for stimulation and recording. One electrode
was attached to the rostral end of the nerve for stimulation and the
second suction electrode attached to the proximal end served to record
the CAP. All recordings were orthodromic. A square stimulation pulse
(30 s duration) was generated by the software QTRAC (Institute of
Neurology, University College London, London, UK) and converted to
current using an isolated linear bipolar constant current stimulator
(Digitimer DS-5 Isolated Bipolar Constant Current Stimulator). The
current was stepwise adjusted to determine maximum CAP signal and
then further increased by 25% (supramaximal stimulation). During an
Figure 2. RNA expression analysis.A, Northern blot of total RNA from E14.5 embryonic fibroblasts hybridizedwith a riboprobe
detecting all versican splice variants. The10 kband13kbbands correspond tomRNAsof versicanV1andV0, respectively.Minor
fragments are products of alternative polyadenylation sites. Loading control: 28S ribosomal RNA. B, Relative expression of
alternative versican transcripts in brains of KO and WT mice at postnatal stages P0, P30, and P100 using quantitative RT-PCR.
mRNA ratios of mutants versus WT (2Ct) were calculated as described in Materials and Methods. C, Immunoblot of brain
extracts using GAG- domain-specific antibodies demonstrates the reduction and the complete loss of versican V2 in heterozy-
gous V0/V2/ and homozygous V0/V2/ animals, respectively. Note that the main portion of mouse versican V2 fromWT
mouse brains seems to be devoid of chondroitin sulfate (band also visible before chondroitinase ABC digestion). The lower V2 core
protein bandmay represent intracellular precursor protein before fullO-glycosylation.D, Immunoblotwith antibodies against the
GAG- domain. Supernatants from embryonic fibroblast cultures lack the V0 isoform in cells from homozygousmice. Samples in
C and Dwere loaded with () or without () preceding treatment with chondroitinase ABC (Ch’ase).
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experiment, the supramaximal CAP was elicited every 10 s. Generated
action potentials were recorded with an isolated bio-amplifier (ISO,
World Precision Instruments), amplified 100 (filter settings: high, 1
kHz; low, 300 Hz). Data were digitized by a data acquisition unit (CED
micro1401MK II, Cambridge ElectronicDesign) using a sampling rate of
100 kHz. Data were acquired and analyzed with the QTRAC software
(Institute of Neurology, University College London). The length of the
conduction distance between the two glass electrodes wasmeasured with
a digital camera and an internal size standard.
Results
Generation of versican V0- and V2-specific knock-out mice
The constitutive knock-out of all versican isoforms is lethal at an
early embryonic stage (Mjaatvedt et al., 1998). We therefore
chose a splice-variant-specific gene inactivation approach to ex-
plore the function of versican V2 in the adult mouse CNS in vivo.
For this purpose, we introduced a translational stop codon into
exon VII of the versican gene (VCAN) preceded by an ER-
retention signal (Fig. 1). This minimal modification, supple-
mented only by a loxP site, was sought to circumvent potential
splicing errors or compensatory expression of other isoforms and
to suppress the secretion of a truncated protein in the recombi-
nant mice. Due to the splicing modality of the versican gene, the
elimination of the expression of the largest V0 isoform conjointly
with versican V2 was unavoidable, however.
Heterozygous and homozygous mice of the newly generated
knock-out mouse strain VCAN(tm1Zim) are viable and fertile,
have a normal life span, exhibit in comparison to their wild-type
littermates no immediately obvious phenotype in the nervous
system and display within the cage environment an inconspicu-
Figure 3. Absence of compensatory expression of other ECM components in versican V0/V2-deficient mice. A, Immunohistochemistry of cerebellar sections of 2-month-old littermates with
antibodies against versican GAG- (versican V2) and GAG- domains (versican V1), brevican, neurocan-C, and aggrecan reveal no compensatory overexpression of versican V1 and other lecticans
in V0/V2-deficient mice. In WT mice, versican V2 and brevican are both present along myelinated fibers, but only versican V2 accumulates at nodes of Ranvier (punctate staining). Brevican and
aggrecan, but not versican V2, form part of perineuronal nets in the deep cerebellar nuclei, while neurocan-C is associated with perineuronal nets of brainstem nuclei (small insets). Scale bars:
overview on the left, 500m; insets, 10m; remaining images, 20m.B, Immunoblots corroborate the basically unaltered content of lecticans and the slight or moderate reductions of TnR and
phosphacan in brain extracts of P30WT and versican V0/V2-deficient mice. Aggrecan and versican V1 evade detection due to their limited expression in mature brain tissues. The values below the
blots represent mean ratios from densitometric measurements of immunoblots of brain extracts from three wild-type versus three V0/V2-null mice. nd, Not done.
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ous behavior. Litters of heterozygous breeding pairs follow a nor-
mal Mendelian inheritance indicating no increased lethality in
association with the versican mutant genotype.
Expression of the versican transcripts in V0/V2
knock-out mice
In line with our targeting strategy to abrogate the versicanV0 and
V2 production only on the protein level and to preserve correct
splicing and normal expression of versican transcripts, we could
find mRNAs of all splice variants in knock-out animals. Never-
theless, the ratios of the different versican transcripts were to
some extend affected in the mutant mice. For instance, Northern
blot analysis of RNA isolated from E14.5 embryonic fibroblasts
showed that versican V0 transcripts were reduced in cells from
heterozygous mice or even evaded detection when they were iso-
lated from homozygous animals (Fig. 2A). In both cases the level
of the V1message remained unchanged in embryonic fibroblasts.
A more sensitive approach using RT-PCR with isoform-specific
primers confirmed however, the presence of versican V0 tran-
scripts in allmutant fibroblast cultures (data not shown). Relative
quantification of versican transcripts in brains of homozygous
versus wild-type littermates by real-time RT-PCR finally demon-
strated that the total amount of versican mRNA was diminished
in knock-out animals of all ages examined (P0, P30, andP100). In
homozygous mice this change in expression resulted from a 90%
reduction of versican V2 mRNA (all ages tested) and a decline of
V0 mRNA to 20% (P0) or 50% (P30, P100) of the level mea-
sured in the wild-type animals (Fig. 2B). In contrast, the relative
expression level of versican V1 mRNA in brain was not influ-
enced by the mutation, and also the V3-transcript stayed rather
stably low.
Proof of absence of versican V0 and V2 core proteins in
homozygous mutants
The efficient elimination of the V0 and V2 core protein expres-
sion in homozygous animals was demonstrated in comparisons
with adult wild-type and heterozygous littermates. Immunoblots
of brain extracts withGAG- domain-specific antibodies showed
that versican V2 protein was significantly reduced in heterozy-
gous and abolished in homozygousmice (Fig. 2C).Moreover, the
absence of the truncated form of V0 and V2 provided indirect
evidence for a successful intracellular degradation in neural cells.
Similarly, immunoblot of spent medium from primary cultures
of E14.5mutant embryonic fibroblasts with anti-GAG- domain
antibodies revealed that homozygous fibroblasts secreted normal
levels of the V1 isoform, but completely lacked the versican V0
core protein (Fig. 2D). The genetic manipulation neither im-
paired viability nor altered the cellular growth rate (data not
shown), confirming the effectiveness of our targeting approach
also in mesenchymal cells.
The complete absence of the V0 and V2 core proteins in the
homozygous mice could ultimately be proven by comparative
Figure 4. Comparative analysis of myelinated fiber tracts in WT and versican V0/V2/mutants. Coronal brain sections of postnatal stages P10, P20, and P90 stained with antibodies against
MBP display no morphological aberrations despite the complete absence of versican V2 in the KO mice. Scale bar, 1 mm.
Figure 5. Visualization of the ECM around the CNS nodes of Ranvier. Double immunofluorescence of cerebellar sections reveals inwild-typemice the nodal accumulation of versican V2 (VcV2) in
relation to the myelin component MBP (A, VcV2, green; MBP, red; sagittal view) and demonstrates its colocalization with TnR (B–D, VcV2, green; TnR, red; transverse view) intermingling with
versican in the perinodal ECM (E, 3D reconstruction based on confocal image stack). Scale bars: A, B (for B–E), 1m.
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immunohistological analyses of wild-type animals and mutants
using our GAG domain-specific antibodies. In wild-type mice,
versican V0 is normally present during early CNS development,
mostly disappearing after birth (data not shown). In contrast,
versican V2 expression initiates postnatally, increasing continu-
ously until it reaches a plateau (mRNA level around P30/protein
level around P90). At this time point, versican V2 has become a
major component of the brain ECM, being associated with the
white matter of the CNS (Figs. 3, 4). In the knock-out strain,
neither the core proteins of versican V0 (includes GAG- and
GAG-) nor those of versican V2 (contains only GAG-) could
be detected by immunohistochemical stainings of embryonic
(data not shown) or postnatal tissues, confirming their effective
abrogation (Figs. 3A, 4, 6, and 7 display examples of cerebellum,
cerebrum, optic nerve, and spinal cord). Intracellular accumula-
tions of truncated products, which would still be recognized by
our antibodies, were not observed, while apoptotic cells stained
by TUNEL technique were at P20 (after the onset of normal
versican V2 expression) similarly scarce in brain sections of mu-
tant and wild-type mice (data not shown).
Effects of the versican V0/V2 knock-out on the expression of
other lecticans
In accordance with our strategy to minimize the impact on the
transcriptional level and to evade potential feedback mecha-
nisms, the lack of versican V2 in the adult CNS of homozygous
mutants was not compensated by increased expression and dep-
osition of the remaining V1 and V3 splice variants (Figs. 2B, 3).
In fact, immunostaining with GAG--specific antibodies re-
vealed that versican V1 stayed in wild-type and knock-out litter-
mates confined to a few tissues, such as the choroid plexus, me-
ninges, and blood vessels (data not shown). Also other lecticans
retained their normal protein levels and distribution in the ab-
sence of versican V2. This is exemplified by immunohistochem-
ical stainings of cerebellar white matter and granular cell layer
and by immunoblotting of whole brain extracts using antibodies
against brevican, neurocan, and aggrecan (Fig. 3A,B, respec-
tively). Similarly, brain ECM structures typically devoid of versi-
can V2 (e.g., the specialized perineuronal nets in the deep cere-
bellar nuclei and/or the brainstem) displayed in the knock-out
mice their characteristic staining patterns for aggrecan, brevican,
and neurocan (Fig. 3, insets). Finally, no compensatory upregu-
lations, but rather slight or moderate reductions of the other
brain ECM molecules TnR and its binding partner phosphacan,
respectively, could be observed in the initial immunoblotting ex-
periments (Fig. 3B).
Histological andmolecular analysis of myelinated fiber tracts
Despite the complete absence of versican V2 and the lack of a
compensatory expression of a related lectican, postnatal brain
development seemed to be mostly unaffected in knock-out mice
(Fig. 4). Hematoxylin-eosin stainings revealed no significant dif-
ferences in comparisons of brain sections from wild-type and
mutant littermates aged P10 or older (data not shown). Also the
formation of the major fiber tracts and myelination appeared
normal, since no alterations could be observed by light micro-
scopical examination of Nissl-stained sections or after immuno-
histochemistry with antibodies against neurofilament-200 (data
not shown) and MBP (Fig. 4). Likewise, the distribution of
GFAP-positive astrocytes was comparable in wild-type and in
knock-out mice (data not shown).
Although the CNS-specific versican V2 is in wild-type mice
present all along the myelinated fibers, it is preferentially depos-
Figure 6. Effect of the versican V2 deficiency on the distribution of nodal, paranodal,
and juxtaparanodal components. In triple/double immunofluorescence of optic nerve
tissue from wild-type (A, C, E) and versican V2-deficient mice (B, D, F ), no difference in
the distribution of paranodal contactin (Cntn: red in A–D) and Caspr (red in E and F ) or
juxtaparanodal potassium channels Kv1.2 (turquoise in A–D) can be observed (VcV2:
green in A and B; Hoechst nuclear staining: blue in A–F ). Also the clustering of the sodium
channel Nav1.6 (green in C–F ) is not impaired. The localization of key components of the
CNS nodes of Ranvier is depicted in the sketch (G) modified from Rasband and Trimmer
(2001). Scale bars: 10m; insets, 2.5m.
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ited at the nodes of Ranvier. Therefore, we focused next onto the
nodal region. For this purpose, we prepared double- and triple-
immunofluorescence stainings of cerebellum, spinal cord, and
optic nerve sections using antibodies against nodal, paranodal,
and juxtaparanodal markers. Our confocal images displayed in
the CNS of wild-type mice a versican V2- and TnR-enriched
extracellular matrix that engulfs the nodes between the compact
MBP-positive myelin sheaths (Fig. 5). Surprisingly, the absence
of versican from this structure had in the mouse mutants no
effect on the distribution of MBP (data not shown), the jux-
taparanodal voltage-gated potassium channel 1.2 (Kv1.2), or the
paranodal Caspr and contactin (Figs. 6, 7).
Also the compact clustering of the voltage-
gated sodium channel 1.6 (Nav1.6) em-
bedded in the axolemma at the node of
Ranvier appeared unaltered in versican
V0/V2-null mice. A limited electron mi-
croscopical analysis of the nodes in the op-
tic nerve revealed a normal organization of
the paranodal loops and regular septate-
like junctions at their axoglial interface
(data not shown).
Disturbed assembly of the extracellular
matrix around the node of Ranvier
In contrast to the normal localization of
these membranous components, the mo-
lecular organization of extracellular ma-
trix surrounding the myelin-free portion
of the CNS nodes is in the V0/V2 knock-
out animals severely affected. This rather
compact ECM forms a 1- to 2-m-wide ring with an outer diam-
eter of 3–4 m (Figs. 5–7). It includes, apart from the tightly
intermingled versican V2 and TnR, also phosphacan (the se-
creted proteoglycan isoformofRPTP) andhyaluronan. Intrigu-
ingly, this specialized meshwork structure is practically absent in
our mutant mice, as the selective ablation of the V2 isoform is
accompanied by the complete loss of tenascin-R and phospha-
can, suggesting a key regulatory function of versican in the assem-
bly of the perinodal extracellular matrix. Nevertheless, TnR and
phosphacan maintain their normal distribution in locations
Figure 7. Simultaneous loss of TnR and phosphacan from nodes of Ranvier in versican V2mutants. Immunohistochemical and immunofluorescence analysis of cerebellum and spinal cordwhite
matter, respectively, with antibodies against versican V2 (GAG- domain), TnR, and phosphacan demonstrates their colocalization in the perinodal ECM in wild-typemice. In versican V2-deficient
mice, TnR and phosphacan are both absent from the CNS nodes of Ranvier, while keeping their normal distribution in perineuronal nets of deep cerebellar nuclei. Paranodal contactin (red) and
juxtaparanodal potassium channel Kv1.2 (turquoise) were immunostained in spinal cord for node localization. Scale bars: cerebellum, 50m; spinal cord, 5m.
Figure 8. Perinodal localization of versican V2 is not affected by absence of TnR. Immunohistochemistry of cerebellar sections
demonstrates that TnR is selectively lost from the nodes of Ranvier in versican V2-deficient animals, while versican V2maintains
its normal distribution in TnR/mice. Scale bar, 10m.
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where versican V2 is usually not present.
This includes the perineuronal nets of the
deep cerebellar nuclei (TnR and phospha-
can) (Fig. 7) as well as the molecular layer
of the cerebellum (phosphacan/RPTP,
data not shown). This specific loss of
tenascin-R and phosphacan from the
nodal ECM of versican V0/V2 knock-out
mice could also be corroborated in other
CNS tissues, such as spinal cord (Fig. 7)
and optic nerve (data not shown).
To confirm that versican V2 recruits
tenascin-R to the nodal matrix and not
vice versa, wemade a comparative analysis
of cerebellar sections from a TnR knock-
out strain (Rauch et al., 2005) with tissue
sections from our versican V0/V2 mutant.
These immunohistological experiments
indeed demonstrated that versican V2 in-
corporated normally into the extracellular
matrix at the nodes of Ranvier, even in the
absence of tenascin-R, while TnR implic-
itly required versican V2 for its deposition
at this location (Fig. 8). Interestingly,
phosphacan was missing from the nodal
matrix of both knock-out strains indicat-
ing that its loss in the CNS of versican
V0/V2 knock-outmice is caused indirectly
by the absence of TnR (data not shown).
Previous in vitro experiments have
demonstrated that the C-type lectin do-
main within the C-terminal G3 region of
versican mediates the binding to
tenascin-R (Aspberg et al., 1997), whereas
the N-terminal G1 domain interacts with
hyaluronan (LeBaron et al., 1992). Be-
cause versican V2 is recruited to the nodal
matrix independently of tenascin-R, we
subsequently tested whether hyaluronan,
its second ligand at the node of Ranvier,
could be responsible for anchoring the
large molecular complex of versican V2,
TnR, and phosphacan. We therefore re-
moved hyaluronan from wild-type cere-
bellar sections by cleavage with the
highly specific Streptomyces hyalurolyti-
cus hyaluronate lyase. Despite the effec-
tive elimination of hyaluronan, the dis-
tribution of versican V2, tenascin-R, and
phosphacan remained unchanged (Fig. 9). The versican V2
immunostaining was also not affected in hyaluronan-depleted
cerebellum sections of tenascin-R-null mutants, demonstrat-
ing that neither ligand is absolutely necessary for its anchorage
in the ECM (data not shown).
Cell surface sulfatides are other neural components interact-
ing in vitro with the C-terminal globular domain of lecticans,
including versican (Miura et al., 1999). We therefore also ana-
lyzed the distribution of the V2 isoform in the myelinated fiber
tracts of brains from mice deficient in UDP-galactose ceramide
galactosyltransferase (CGT) (Bosio et al., 1996). CGT is a key
enzyme in the biosynthesis of galactocerebroside (GalC) and its
sulfated derivative, sulfatide, both major lipid constituents of
myelin. Although CGT-knock-out mice completely lack axoglial
junctions in the CNS paranodes and die shortly after onset of
myelination, they displayed 19 d after birth no abnormal dis-
tribution of versican V2 and tenascin-R in cerebrum and cerebel-
lum (Fig. 10). Even additional enzymatic removal of hyaluronan
from the brain sections of CGT-null mice did not result in the
release of versican V2 from the newly formed nodes of Ranvier.
These experiments indicate that the cell surface sulfatide lipids
are, unlike versican V2, not directly involved in the assembly of
the nodal extracellular matrix.
Conduction velocity is not affected in absence of versican V2
To test whether the absence of versican V2 from the perinodal
matrix in the CNS would affect the conductivity of the myelin-
ated fiber tracts in our knock-out strain, we determined the elec-
Figure 9. Hyaluronan is not responsible for anchoring the perinodal matrix. Complete removal of hyaluronan by treating
cerebellar sections with Streptomyces hyalurolyticus hyaluronate lyase (HA-lyase) has no effect on the distribution of versican V2
and TnR inWTmice. Sections were stained with corresponding antibodies to reveal the localization of the ECM proteins andwith
biotinylated hyaluronic acid-binding protein (B-HABP) to visualize hyaluronan. Scale bar, 20m.
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trophysiological characteristics of CAPs at 26°C and 37°C (Fig.
11).We chose these two temperatures because the optic nerves of
C57BL/6J backgroundmice are very short and the discrimination
of different populations of nerve fibers by their conduction ve-
locity becomes clearer at lower than physiological temperatures.
The net conduction distances were in our set-up finally 3.75 
0.14mm for wild-type and 3.59 0.18mm for V0/V2 knock-out
mice (mean  SEM; n  13 and n  6, respectively). For both
mutant and wild-type strains, all recorded CAPs showed a three-
peak shape, which is characteristic for rodent optic nerves (Fig.
11A). With increasing stimulus intensities, the CAP profile
changed. The peaks and the nadir of the CAP successively shifted
to slightly lower latencies. Additionally, the stimulus artifact be-
came more pronounced, affecting in a few recordings of very
short nerves the shape of peak 1 and rarely peak 2. In these cases,
the corresponding latencies were excluded from the calculations.
In complete agreement with a previous report (Allen et al., 2006),
the peak with the shortest latency appeared first, followed by
peaks 2 and 3 with increasing stimulation strength. Compared
with wild-type control, the current needed to elicit a maximal
CAP (wild type: 6.37  0.47 mA; V0/V2/: 5.96  0.72 mA,
mean SEM) was not different in V0/V2/ animals.
We subsequently determined conduction velocities of the
three peaks and the nadir by dividing the conduction distance of
the recorded nerve by the latency measured from the stimulus
onset to the peak. In both groups, the conduction of all peaks
slowed equally down, when the temperature was reduced from
37°C to 26°C; wild type: 34.7% slowing, V0/V2/: 33.8% slow-
ing (Fig. 11B). The variability of the conduction velocity between
the different optic nerves was very small for peaks 2 and 3. It was
slightly higher in regard to peak 1, which is most probably due to
an increased influence of the stimulus artifact. Finally, the mean
conduction velocities of the three peaks were highly similar for
wild-type and mutant animals independent of the temperature,
at which the CAPs were measured.
Discussion
Our previous studies, first identifying the
versican isoform V2 as major constituent
of adult brain extracellular matrices
(Dours-Zimmermann and Zimmermann,
1994; Schmalfeldt et al., 1998), then re-
vealing its characteristic expression pat-
tern in myelinated fiber tracts of the CNS
and subsequently demonstrating its po-
tent inhibitory properties on axonal
growth (Schmalfeldt et al., 2000) in vitro,
prompted us to generate a knock-out
mouse model to further explore the func-
tion of this CNS-specific lectican in vivo.
Due to the early intrauterine lethality
caused by the constitutive elimination of
all versican splice variants in hdf mice
(Mjaatvedt et al., 1998), we had to choose
between (1) a conditional knock-out ap-
proach, potentially facing difficulties with
efficiency, timing, and tissue specificity of
the versican gene ablation, or (2) an
isoform-selective knock-out, which would
only affect the alternatively spliced exon
VII, but would also abolish the expression
of the more widely distributed V0 variant
alongwith the CNS-restricted versicanV2.
Since versican V0 appears to be always coexpressed with versican
V1 (Dours-Zimmermann and Zimmermann, 1994; Zimmer-
mann et al., 1994; Landolt et al., 1995; Dutt et al., 2006), we
considered the collateral elimination of versican V0 the minor
problem, and finally opted for the latter approach. For this pur-
pose, we designed a novel strategy that ultimately left the expres-
sion of versican V1 and V3 intact, effectively prevented compen-
sation by other versican splice variants and successfully
circumvented the secretion of an artificially truncated core pro-
tein that potentially could cause a dominant side effect. Although
we originally attempted to maintain normal mRNA levels of all
versican splice variants in the genetically manipulated
VCAN(tm1Zim) strain and to disrupt V0 and V2 production and
secretion only via a premature stop codon and an ER-retention
signal, instead, the complete annihilation of versican V0 and V2
in the mutants has most probably to be attributed to combined
action of a nonsense-mediated decay mechanism reducing the
proportion ofV0 andV2 transcripts (for review, seeKuzmiak and
Maquat, 2006) and efficient intracellular clearance of the few
truncated core proteins translated from the mutated mRNAs.
The normal reproduction behavior, litter size, andMendelian
distribution of wild-type, heterozygous, and homozygous prog-
eny indeed confirmed our prediction that the early embryonic
lethality of hdf mice is mostly caused by the absence of versican
V1 and consequently could be overcome by keeping the expres-
sion of this isoform unchanged in our mutants. Similar to the
single gene inactivation of other prominent myelin-derived in-
hibitors of axonal growth like Nogo, MAG (myelin-associated
glycoprotein), and oligodendrocyte myelin glycoprotein
(OMgp) (Zurn and Bandtlow, 2006), the abolition of the CNS-
restricted versican V2 alone had no apparent effect on the forma-
tion of fiber tracts. Versican V2 deficiency neither led to excessive
axonal sprouting nor caused myelination defects in the develop-
ing CNS. Albeit very difficult to discern from immunofluores-
cence experiments, increased collateral axon branching at the
Figure 10. The perinodal accumulation of versican V2 does not depend on sulfatide-mediated cell surface binding. Immuno-
histochemical analysis of cerebellar sections reveals the normal deposition of versicanV2 and TnR around the newly formednodes
of Ranvier in 19-d-old (CGT/) mice despite their deficiency in the biosynthesis of sulfatide, a glycolipid ligand of versican in
vitro. Scale bar, 20m.
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nodes of Ranvier or enlargement of the
nodal region was not evident. Since the
proper formation and stabilization of fiber
tracts and synaptic contacts in the CNS
certainly involves inhibitory activities of
many cell surface and ECM molecules,
functional redundancy may explain why
dramatic histological changes are only
rarely observed in single mutants. These
include also the brevican and neurocan
knock-out strains, which both displayed
no alterations upon histological examina-
tion (Zhou et al., 2001; Brakebusch et al.,
2002). While neurocan forms mostly part
of the embryonic and perinatal CNS ma-
trix, brevican expression initiates postna-
tally and overlaps to a certain extent with
versican V2 in the spaces between myelin-
ated fibers. It is therefore conceivable that
a lack of versican V2 would at least partly
be compensated by brevican. Hence, elim-
inating both of these “late” lecticans in
double knock-out mutants may be re-
quired to clarify their functional involve-
ment in fiber tract stabilization.
Redundancy may also obscure the pos-
tulated function of versican V2 in forming
a perinodal ion pool for rapid generation
and propagation of action potentials, as
CAP measurements of optic nerves re-
vealed no abnormalities in our single mu-
tants. This is somewhat surprising, as a re-
duced conduction velocity has been
reported for mice lacking TnR (Weber et
al., 1999), which is also absent from the
nodal matrix in our knock-out strain. The
discrepancy may be connected to the fact
that the strain background in those com-
parative experiments was not uniform and
that the resolution of nowadays CAP re-
cordings permits an individual analysis of the three timely spaced
signals also in mice.
Brevican, aggrecan, and neurocan concentrate along with
TnR in perineuronal nets engulfing perikaryon, proximal den-
drites, and particularly AISs of large CNS neurons. Conversely,
versican V2, is predominantly deposited in an analogous ECM
structure at the nodes of Ranvier. Despite this intriguing accu-
mulation occurring already during the establishment of the
nodes (Oohashi et al., 2002), versican V2 may not be directly
involved in controlling the initial steps of their formation. Unaf-
fected Nav channel clustering at the CNS nodes and accurate
localization of paranodal and juxtaparanodal components in our
mutants argue against a role of versican V2 as functional analog
of gliomedin, the glial organizer of the nodal structure in the
peripheral nervous system (Eshed et al., 2005). Furthermore, the
concomitant absence of node-associated TnR and phosphacan
and the lack of compensatory expression of aggrecan, neurocan,
or other versican isoforms in ourmicemake it unlikely that any of
these ECM proteins are related to the oligodendrocyte-derived
soluble factors reported to induce node-like Nav clustering in
vitro (Kaplan et al., 1997). Nevertheless, we cannot entirely ex-
clude that protein complexes of the paranodal junctions or brevi-
can, which may also accumulate at a few large diameter nodes
(Bekku et al., 2009), could substitute such a hypothetical cluster-
ing activity of versican V2 in the CNS.
Instead, the data from our versican V0/V2 knock-out strain
clearly point toward a key role of versican V2 in the assembly of
the extracellular structure surrounding and possibly stabilizing
the CNS nodes. The conjoint loss of versican V2, tenascin-R, and
phosphacan from the nodal matrix in ourmutants now confirms
in vivo macromolecular interactions formerly postulated on the
basis of in vitro findings. This includes interactions between ver-
sican V2 and tenascin-R (Aspberg et al., 1997) and between
tenascin-R and phosphacan (Xiao et al., 1997; Milev et al., 1998).
Since phosphacan is also absent from the nodes of Ranvier in
TnR-null mice (Weber et al., 1999), we conclude that versican V2
first recruits tenascin-R, which in turn integrates phosphacan
into the matrix. Additional components joining the complex are
hyaluronan and its binding partner Bral1, which shortly follows
versican V2 expression during postnatal development (Oohashi
et al., 2002). Bral1 possibly stabilizes the interaction between hya-
luronan and theN-terminal G1 domain of versican, whereas TnR
may cross-link the versican G3 domain at the other end of the
core protein. Hyaluronan certainly forms the backbone for ver-
sican aggregates. Yet, hyaluronan is unlikely to increase the ver-
sican deposition around the nodes because of its uniform distri-
Figure 11. Electrophysiological characteristics of CAPs of optic nerves at 26°C and 37°C. A, Four representative CAPs from
wild-typeandV0/V2/micearedisplayed. The0.03ms square-wave stimuluswasappliedat timepoint 0on the timeaxis. Four
sweeps per CAP show the response to four increasing stimulus strengths. The lowest sweep is the response to a stimulus of 10%
of the current needed to elicit the maximal CAP. The last sweep shows the maximal CAP. The stimulus artifacts appear as very
narrow spikes at0ms.With increasing stimulus current, peakswith different latencies develop, forming the typical three-peak
shape of a rodent optic nerve CAP (calibration, 1 mV). No apparent difference between wild-type and the V0/V2/mice was
observed. B, Conduction velocities of the three peaks and the nadir were determined by dividing the conduction distance of the
recorded nerve by the latency,measured from the stimulus onset to the peak. At both temperatures, the conduction velocities for
peaks and the nadir were virtually identical for wild-type and V0/V2/mice (mean SEM).
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bution along the myelinated fiber tracts. Moreover, our
hyaluronan-degradation experiments demonstrate that the bind-
ing of versican V2 is not crucially dependent on interactions with
hyaluronan and TnR alone or in combination. Considering all
these observations, we propose a model, in which the accumula-
tion of versican V2 around the CNS nodes of Ranvier forms the
extracellular nucleation point for the subsequent assembly of the
perinodal matrix.
Accordingly, the deposition of the versican-enrichedmatrix at
the nodes is likely to be initiated by a firm interaction of versican
V2with the nodal axolemmaor, less probable, with the paranodal
structure, while previously reported binding activities of its part-
ner TnR and/or phosphacan to paranodal contactin (Bru¨mmen-
dorf et al., 1993; Peles et al., 1995) and neurofascin-155 (NF-155)
(Volkmer et al., 1998) or to the nodal sodium channels (Sriniva-
san et al., 1998; Ratcliffe et al., 2000) may play either no or only
subordinate roles inmatrix anchoring. The prominent paranodal
components contactin, NF-155, Caspr, and sulfatide [interacts
with versican in vitro (Miura et al., 1999)] seem also not necessary
for the selective deposition and binding of versican V2 at the
nodes. In CGT-null mice, they are all virtually absent from the
severely disturbed terminal glial loops of the paranodes (Poliak et
al., 2001;Marcus et al., 2002). Nevertheless, versican V2 and TnR
accumulate normally in CGT mutants, as demonstrated by our
immunohistochemical analyses. Hence, cell surface proteins se-
lectively localized within the nodal axolemma are more promis-
ing candidates for the versican-dependent anchoring of the peri-
nodal extracellular matrix. In the adult CNS, potential
membrane receptors of versican are voltage-gated sodium chan-
nels (mainly Nav 1.6) and neurofascin-186 (NF-186). Hedstrom
et al. (2007) recently showed that a knockdown of NF-186 by
RNA interference abolished the recruitment of the close versican-
relative brevican to the perineuronal net covering the AIS of sev-
eral subsets of CNS neurons. Since NF-186 is also crucially in-
volved in the nodal assembly (Zonta et al., 2008), it seems
conceivable that it similarly accumulates and immobilizes the
ECM at the CNS nodes of Ranvier via a versican V2-mediated
interaction. Yet, direct binding of NF-186 to brevican and/or
versican V2 has still to be demonstrated.
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